πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 3,720 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 6680176

Identification of candidate ligands which modulate antigen presenting cells

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jan 20 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6680060

Hepatitus A virus vaccines

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jan 20 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6676973

Method of treating ovarian cancers with cadmium

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jan 13 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6676936

Chimeric and/or growth-restricted flaviviruses

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jan 13 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6673905

Conjugation of biomolecules using Diels-Alder cycloaddition

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jan 06 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6673559

Met proto-oncogene and a method for predicting breast cancer progression

The United States of America as Represented by the Government of the Department of Health and Human Services Β· Granted Tue Jan 06 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6673342

Recombinant human IgA-J chain dimer

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jan 06 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6670374

Swainsonine compounds as inhibitors of toxin receptor expression

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Dec 30 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6669962

Starch microcapsules for delivery of active agents

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Dec 30 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6669935

Delivery of therapeutic agents by gene therapy

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 30 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6664374

Polypeptides comprising IL-6 ligand-binding receptor domains

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 16 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6664263

1,8-naphthalimide imidazo{4,5,1-de}acridones with anti-tumor activity

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 16 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6664227

Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 16 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6660750

Flavopiridol methods and compositions for HIV therapy

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 09 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6660488

Antibodies for the alpha platelet-derived growth factor receptor

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 09 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6660273

Chimeric vaccine against tick-borne encephalitis virus

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 09 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6656930

Aralkyl diazabicycloalkane derivatives for CNS disorders

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 02 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6656706

Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 02 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6653505

3-Methoxybenzyl thiourea derivatives and improved lipid compositions containing same

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Nov 25 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6653084

Anti-erbB-2 antibodies to human receptor related to but distinct from EGF receptor

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Nov 25 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6649621

Prevention or reversal of sensorineural hearing loss (SNHL) through biologic mechanisms

United States of America as represented by the Secretary of the Air Force Β· Granted Tue Nov 18 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6649411

Methods of inhibiting cancer cells with ADNF III antisense oligonucleotides

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Nov 18 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6642049

Human brain endothelial cells and growth medium and method for expansion of primitive CD34

United States of America as represented by the Secretary of the Air Force Β· Granted Tue Nov 04 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6641815

Sequestrin

The United States of America as represented by the Secretary of the Army Β· Granted Tue Nov 04 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired